A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: 5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer. According to the Food & Drug Administration FDA’s MedWatch:
Two large, randomized controlled trials showed an increased incidence of high-grade prostate cancer with finasteride and dutasteride treatment.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: 5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.